GRHL2 and breast neoplasm: Clinical data gathered from patients with ER-positive breast cancer not only reveal increased GRHL2 in breast tumors compared to normal tissues, but emphasize an association between high levels of GRHL2 expression and reduced disease-free survival [7,16,25,26].